Waycross Partners, LLC Amgen Inc Transaction History
Waycross Partners, LLC
- $723 Million
- Q3 2024
A detailed history of Waycross Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Waycross Partners, LLC holds 2,250 shares of AMGN stock, worth $590,017. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,250
Previous 2,250
-0.0%
Holding current value
$590,017
Previous $703,000
2.99%
% of portfolio
0.1%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding AMGN
# of Institutions
3,119Shares Held
407MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$13.7 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$7.69 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$3.85 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$3.74 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $140B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...